Do not sell this group short. They will succeed inspite of themselves. Olympus has picked up on how incompetent their management team is, and will cull them them. The rank and file remaining have many years experience in the ENT business and if allowed to "do their thing" will bring this sinking ship back.
Olympus is a strong marketing company, something Gyrus was terrible at.
If the ENT group gets back to basics, those businesses that they dominated for the last 60 years, they will profitably survive.... and could flourish.
They will not, however be an 30% growth company. Few will in the medical device industry going forward.